Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Five Late-Breakers To Watch For At ASCO 2021

May 20 2021

• By Alexandra Shimmings

Cancer - DNA - test tube

Related Content

As China Prices Drop, Junshi Looks To Coherus To Take PD-1 Global

Feb 04 2021

Merck & Co.’s Keytruda Stakes Another Adjuvant Flag, In RCC

Apr 08 2021

Novartis's Targeted Radioligand Improves OS And PFS In Prostate Cancer

Mar 23 2021

ESMO: BMS’s Opdivo Edges Merck & Co’s Keytruda In First-Line Advanced Gastroesophageal Cancers

Sep 30 2020

Related Companies

AstraZeneca PLC

Pfizer Inc.

GSK plc

Shanghai Junshi Biosciences Co., Ltd.

Coherus Oncology, Inc.

Novartis AG

Merck & Co., Inc.

Bristol Myers Squibb Company

Additional Topics

Clinical Trials Companies ImmunoOncology Research & Development ASCO Cancer BioPharmaceutical

More from ASCO

More from Conferences

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.